| Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer (NCT01170299) | Royal Marsden NHS Foundation Trust | 2009-10-01 |
| Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver (NCT00766220) | M.D. Anderson Cancer Center | 2009-10-01 |
| OPTIMOX1 in Chinese mCRC Patients (NCT01023633) | Nanjing Medical University | 2009-10-01 |
| Narrative or Fact-Based Videos in Increasing Colorectal Cancer Screenings in African American Communities (NCT02100254) | Roswell Park Cancer Institute | 2009-10-01 |
| The FLU-FOBT Program in Primary Care Settings Where Disparities Persist (NCT01211379) | University of California, San Francisco | 2009-10-01 |
| Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China (NCT01110941) | Shen Lin | 2009-09-01 |
| Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer (NCT00903396) | Alliance for Clinical Trials in Oncology | 2009-09-01 |
| Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage III Colorectal Cancer (NCT00995202) | Federation Francophone de Cancerologie Digestive | 2009-09-01 |
| A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer (NCT01051596) | Georgetown University | 2009-09-01 |
| Compare FOFLOX4 in Preoperative and Postoperative and Postoperative in Resectable Liver Metastasis Colorectal Cancer (MCC) (NCT01035385) | Guangdong Provincial People's Hospital | 2009-09-01 |
| The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function (NCT00973557) | Cedars-Sinai Medical Center | 2009-09-01 |
| Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus Irinotecan (NCT01004159) | Roswell Park Cancer Institute | 2009-09-01 |
| Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy (NCT00967616) | Daiichi Sankyo | 2009-09-01 |
| Multi-modality Imaging in the Prediction of Response to Systemic Treatment in Colorectal Cancer (NCT01292681) | Radboud University Medical Center | 2009-08-01 |
| Study to Identify Mechanisms of Resistance to Standard Therapy in Patients With Metastatic Colorectal Cancer (NCT00984048) | Jewish General Hospital | 2009-08-01 |
| Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy (NCT00986440) | Daiichi Sankyo | 2009-07-31 |
| Internet-Based Weight-Loss Program for Colorectal Cancer Survivors (NCT01032590) | Rutgers, The State University of New Jersey | 2009-07-01 |
| 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors (NCT00967577) | Weill Medical College of Cornell University | 2009-07-01 |
| Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer (NCT00975897) | Medical Research Council | 2009-07-01 |
| An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer (AXIOM) (NCT01697462) | Hoffmann-La Roche | 2009-07-01 |
| Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer (NCT00967655) | Loma Linda Oncology Medical Group, Inc. | 2009-07-01 |
| Evaluation of an Intervention to Increase Colorectal Cancer Screening in Primary Care Clinics (NCT00737646) | Centers for Disease Control and Prevention | 2009-07-01 |
| Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal Surgery (NCT00973869) | University of Leicester | 2009-07-01 |
| S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by Surgery (NCT00974389) | Osaka Medical College | 2009-07-01 |
| Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients (NCT01507740) | Medical University Innsbruck | 2009-07-01 |
| Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer (NCT05278728) | Biotech Pharmaceutical Co., Ltd. | 2009-07-01 |
| A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin (NCT01077739) | Hoffmann-La Roche | 2009-07-01 |
| Prognostic Value of Tissue Factor (TF) in Blood t in Colorectal Cancer in Adults (NCT02304978) | University Hospital, Lille | 2009-06-22 |
| Phase I Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Participants With Colorectal Cancer (MK-0646-016) (NCT00925015) | Merck Sharp & Dohme LLC | 2009-06-17 |
| Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer (NCT00819208) | Canadian Cancer Trials Group | 2009-06-02 |
| New Individualized Therapy Trial for Metastatic Colorectal Cancer (NCT00867334) | Inova Health Care Services | 2009-06-01 |
| OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer (NCT00940303) | Hoffmann-La Roche | 2009-06-01 |
| Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity (NCT01149304) | University of Magdeburg | 2009-06-01 |
| Efficacy and Safety Study of Imprime PGG With Cetuximab in Subjects With Stage IV KRAS-Mutated Colorectal Cancer (NCT00912327) | HiberCell, Inc. | 2009-06-01 |
| Vitamin E Supplements in Treating Patients Undergoing Surgery for Colorectal Cancer (NCT00905918) | Rutgers, The State University of New Jersey | 2009-06-01 |
| Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery (NCT00960427) | Barbara Ann Karmanos Cancer Institute | 2009-06-01 |
| Colon Cancer Prevention Study (NCT00924690) | University of North Carolina, Chapel Hill | 2009-06-01 |
| Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer (NCT00958737) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2009-05-12 |
| Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status (NCT00912743) | AstraZeneca | 2009-05-01 |
| Safety and Efficacy Study of FOLFOX4+Panitumumab vs.FOLFIRI+Panitumumab in Subjects WT KRAS Colorectal Cancer and Liver-only Metastases (NCT00885885) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2009-05-01 |
| The Northern-European Initiative on Colorectal Cancer (NCT00883792) | Oslo University Hospital | 2009-05-01 |
| Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer (NCT00842257) | Massachusetts General Hospital | 2009-05-01 |
| Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer (NCT01006369) | Rutgers, The State University of New Jersey | 2009-05-01 |
| Surgical Resection Lowers Oxidative Stress Markers in Patients With Colorectal Cancer (NCT01470586) | G. Hatzikosta General Hospital | 2009-05-01 |
| Tailored Web-Based Intervention for Cancer Patients and Family Caregivers (NCT01415089) | University of Michigan | 2009-05-01 |
| Studying Lymph Nodes in Patients With Stage II Colon Cancer (NCT00949312) | Saint John's Cancer Institute | 2009-05-01 |
| PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors (NCT00819780) | Amgen | 2009-04-24 |
| Prognostic Factors for Patients With Advanced Colorectal Cancer Treated With Cetuximab. (NCT01068132) | Regione Lombardia | 2009-04-01 |
| Prognostic Value of the Lymphocytic Infiltrate in Colon Cancers (NCT02557061) | University Hospital, Rouen | 2009-04-01 |
| Study of Tumor Samples From Patients With Stage III Colon Cancer Who Have Undergone Surgery and Chemotherapy (NCT00918827) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2009-04-01 |
| Testing Interventions to Motivate and Educate (NCT01568151) | Ohio State University Comprehensive Cancer Center | 2009-04-01 |
| Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery (NCT00936832) | Federation Francophone de Cancerologie Digestive | 2009-04-01 |
| An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ... (NCT00924092) | National Cancer Institute (NCI) | 2009-03-13 |
| Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer (NCT00873275) | City of Hope Medical Center | 2009-03-11 |
| Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer (NCT00838578) | Kyowa Kirin Co., Ltd. | 2009-03-01 |
| The Continuing Care Needs in Colorectal Cancer Patients in Different Stages (NCT00961129) | National Taiwan University Hospital | 2009-03-01 |
| Comparison of Two Methods of Administration of a PEG Solution (NCT00626054) | Rabin Medical Center | 2009-03-01 |
| Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases (NCT00866944) | Amgen Research (Munich) GmbH | 2009-03-01 |
| Outreach for Patients That Are Newly Eligible for Colorectal Cancer Screening (NCT00860249) | Northwestern University | 2009-03-01 |
| An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (RELEVANT) (NCT01697449) | Hoffmann-La Roche | 2009-03-01 |
| External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer (NCT00869570) | Swiss Cancer Institute | 2009-03-01 |
| The Natural History of Solid Organ Cancer Stem Cells (SOCSC) (NCT00923052) | National Cancer Institute (NCI) | 2009-02-09 |
| Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan (NCT00748215) | M.D. Anderson Cancer Center | 2009-02-04 |
| S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer (NCT00686166) | SWOG Cancer Research Network | 2009-02-01 |
| S9304A Study of Protein Expression in Tumor Tissue Samples From Patients With Stage II or Stage III Rectal Cancer Enrolled in Clinical Trial SWOG-9304 (NCT00972751) | SWOG Cancer Research Network | 2009-02-01 |
| Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin (NCT00831571) | Dana-Farber Cancer Institute | 2009-02-01 |
| Vitamin D Supplement in Preventing Colon Cancer in African Americans With Colon Polyps (NCT00870961) | Northwestern University | 2009-02-01 |
| QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors (NCT00819169) | NantCell, Inc. | 2009-01-16 |
| Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥ 75 Years) (NCT00812864) | University Hospital, Limoges | 2009-01-01 |
| Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer (NCT00719199) | EMD Serono | 2009-01-01 |
| Study of Biomarkers in Blood & Tissue Samples From Patients With Colorectal Cancer or Polyps & Patients Without Polyps (NCT00898378) | Indiana University | 2009-01-01 |
| Comparison of Laparoscopic and Open Surgery for Colorectal Malignancy in Obese Patients (NCT06221878) | Chang Gung Memorial Hospital | 2009-01-01 |
| Effect of Preoperative Chemoradiotherapy on Exercise Capacity as Measured by Cardiopulmonary Exercise Testing (NCT00833508) | Imperial College London | 2009-01-01 |
| Promoting CRC Screening in an Urban Minority Population (NCT02392143) | Teachers College, Columbia University | 2009-01-01 |
| Primary Tumor Sidedness Associated With Clinical Characteristic and Postoperative Outcomes in Colon Cancer: a Propensity Score Matching Study (NCT06184555) | Chang Gung Memorial Hospital | 2009-01-01 |
| Nutrition and Lifestyle Study Cohort of Colorectal Cancer in China (NCT02215642) | State Key Laboratory of Cancer Biology | 2009-01-01 |
| Expressive Disclosure and Colorectal Cancer (NCT00853203) | M.D. Anderson Cancer Center | 2009-01-01 |
| Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer (NCT01087268) | Royal Marsden NHS Foundation Trust | 2009-01-01 |
| Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer (NCT00836992) | Mayo Clinic | 2009-01-01 |
| Prognostic Value of Each Codon-specific KRAS Mutation in Colorectal Cancer (NCT05657210) | Seoul National University Bundang Hospital | 2009-01-01 |
| Non-interventional Observational Study of Helical Tomotherapy for Oligometastatic Colorectal Cancer (NCT00807313) | Universitair Ziekenhuis Brussel | 2008-12-01 |
| NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer (NCT00856375) | Nektar Therapeutics | 2008-12-01 |
| Capiri-sutent Phase-1 in Advanced Colo-rectal Cancer (NCT00777478) | Radboud University Medical Center | 2008-12-01 |
| Formative Study of Tailored Survivor Health Promotion (NCT00825240) | M.D. Anderson Cancer Center | 2008-12-01 |
| Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers (NCT00565708) | National Cancer Centre, Singapore | 2008-12-01 |
| Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CT (NCT00823810) | Turku University Hospital | 2008-12-01 |
| Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer (NCT00950144) | City of Hope Medical Center | 2008-12-01 |
| Pilot Study of a Geriatric Intervention After Colorectal and Lung Cancer Surgery (NCT01416168) | H. Lee Moffitt Cancer Center and Research Institute | 2008-12-01 |
| Differences in Timely Cancer Diagnosis in African American and Caucasian Patients With Newly Diagnosed Colorectal Cancer (NCT00856115) | Case Comprehensive Cancer Center | 2008-11-01 |
| A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma (NCT00752570) | Amgen | 2008-11-01 |
| Colorectal Cancer Screening in Average-risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy (NCT00906997) | Hospital Clinic of Barcelona | 2008-11-01 |
| SS-GCC1- Screening Study of Genetic Changes in Colorectal Cancer (NCT00825110) | Royal Marsden NHS Foundation Trust | 2008-11-01 |
| Caring for Those Who Share: Improving the Health of Wisconsin Blood Donors (NCT00772083) | Medical College of Wisconsin | 2008-11-01 |
| Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC (NCT00755534) | Hellenic Oncology Research Group | 2008-11-01 |
| Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cancer (NCT00814619) | Swiss Cancer Institute | 2008-11-01 |
| Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer (NCT00895323) | Garden State Cancer Center at the Center for Molecular Medicine and Immunology | 2008-11-01 |
| Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC) (NCT00788957) | NantBioScience, Inc. | 2008-10-27 |
| Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA's, and Their Targets in Colorectal Cancer Progression (NCT03309722) | University of Southampton | 2008-10-10 |
| RCT of Air Insufflation Versus Water Infusion Colonoscopy by Supervised Trainees (NCT00841282) | East Bay Institute for Research and Education | 2008-10-01 |
| A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer. (NCT00778102) | Hoffmann-La Roche | 2008-10-01 |